Patrick has developed deep methodological expertise advising pharma and biotech firms during his more than 10 years in serving clients. His core competencies span across R&D and Commercial, developing solutions from early research asset strategies over late-stage prioritization to medical affairs reorganizations. He is a well-known expert around portfolio management, asset valuations and market entry strategies across a diverse set of therapeutic areas. Patrick has supported a variety of different organization types in the US, Europe and Asia to identify growth opportunities and increase shareholder value.
Prior to ClearView, Patrick held positions at A.T. Kearney, where he was part of the European Health & Lifesciences leadership team, built the European Center of Excellence for Biotechnology, and leveraged Data Science and Artificial Intelligence for faster and more robust decision making in R&D.
He holds an MBA of the University of St. Gallen, Switzerland and conducts research on strategic decision making at the IE University, Spain.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson